The bankruptcy of genetic-testing pioneer 23andMe is a powerful cautionary tale. After going public in 2021 with a $3.5 billion valuation, the company’s market cap plummeted to less than $13.5 million ...

In this episode, we’ll explore how we’ve created and used genetically modified organisms. Humans love to play with their food—in fact, we’ve been doing it for thousands of years. In this episode of ...